Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
25/20
Brand Signal
2/15
Depth
2/15
5-Axis Cultural Radar
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
